Evidence map›Paper›PMID 24782789›Full record

ReviewFrontiers in psychiatry2014

Stress, Inflammation, and Cellular Vulnerability during Early Stages of Affective Disorders: Biomarker Strategies and Opportunities for Prevention and Intervention.

Adam J Walker, Yesul Kim, J Blair Price, Rajas P Kale, Jane A McGillivray, Michael Berk, Susannah J Tye

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in psychiatry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 62 citations in OpenAlex.

  1. Supervised, Vigorous Intensity Exercise Intervention for Depressed Female Smokers: A Pilot Study.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2017
    Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Telomeres, early-life stress and mental illness.Advances in psychosomatic medicine · 2015
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Adam J WalkerDepartment of Psychiatry and Psychology, Mayo Clinic , Rochester, MN , USA ; School of Psychology, Deakin University , Melbourne, VIC , Australia.
Yesul KimDepartment of Psychiatry and Psychology, Mayo Clinic , Rochester, MN , USA ; School of Psychology, Deakin University , Melbourne, VIC , Australia.
J Blair PriceDepartment of Psychiatry and Psychology, Mayo Clinic , Rochester, MN , USA.
Rajas P KaleDepartment of Psychiatry and Psychology, Mayo Clinic , Rochester, MN , USA ; School of Engineering, Deakin University , Geelong, VIC , Australia.
Jane A McGillivraySchool of Psychology, Deakin University , Melbourne, VIC , Australia.
Michael BerkSchool of Medicine, Deakin University , Geelong, VIC , Australia ; Department of Psychiatry, University of Melbourne , Melbourne, VIC , Australia ; Orygen Youth Health Research Centre , Melbourne, VIC , Australia ; The Florey Institute of Neuroscience and Mental Health , Melbourne, VIC , Australia.
Susannah J TyeDepartment of Psychiatry and Psychology, Mayo Clinic , Rochester, MN , USA ; School of Psychology, Deakin University , Melbourne, VIC , Australia ; Department of Psychiatry, University of Minnesota , Minneapolis, MN , USA.
Deakin University · AUMayo Clinic · USOrygen Youth Health · AUWinnMed · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The mood disorder prodrome is conceptualized as a symptomatic, but not yet clinically diagnosable stage of an affective disorder. Although a growing area, more focused research is needed in the pediatric population to better characterize psychopathological symptoms and biological markers that can reliably identify this very early stage in the evolution of mood disorder pathology. Such information will facilitate early prevention and intervention, which has the potential to affect a person's disease course. This review focuses on the prodromal characteristics, risk factors, and neurobiological mechanisms of mood disorders. In particular, we consider the influence of early-life stress, inflammation, and allostatic load in mediating neural mechanisms of neuroprogression. These inherently modifiable factors have known neuroadaptive and neurodegenerative implications, and consequently may provide useful biomarker targets. Identification of these factors early in the course of the disease will accordingly allow for the introduction of early interventions which augment an individual's capacity for psychological resilience through maintenance of synaptic integrity and cellular resilience. A targeted and complementary approach to boosting both psychological and physiological resilience simultaneously during the prodromal stage of mood disorder pathology has the greatest promise for optimizing the neurodevelopmental potential of those individuals at risk of disabling mood disorders.

Indexed as

biomarkerbipolarcellular resiliencedepressioninflammationplasticityprodromestress

Identifiers

PMID24782789
PMCPMC3988376
OpenAlexW2147210747

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.